Summarized by Masters of Longevity from Longevity Technology.
Noninvasive neuromodulation showed clinical benefit signals in mild Alzheimer’s.

Key Takeaways
- HOPE reported positive clinical signals in mild Alzheimer’s.
- A noninvasive neuromodulation device was tested in patients.
- Results were presented at the Clinical Trials on Alzheimer’s conference.



